42291-272 : Eszopiclone 2 mg Oral Tablet, Film Coated


NDC42291-272
Labeler: Avkare, Inc.
Product Type: Human Prescription Drug
Drug Name:  Eszopiclone
Dosage Form: Oral Tablet, Film Coated
Application #: ANDA091169
Rev. Date: 
CSA Schedule: CIV (US) [1]


[1] Schedule IV Controlled Substance: Low potential for abuse relative to substances in Schedule III. Examples include Alprazolam (Xanax), Diazepam (Valium), Carisoprodol (Soma), Clonazepam (Klonopin), Lorazepam (Ativan), Clorazepate (Tranxene), Midazolam (Versed), Temazepam (Restoril), and Triazolam (Halcion).. More Details: US Dept of Justice Controlled Substance Schedules.

Appearance:


Markings: 93;E8
Shapes:  Round
Colors:  White
Size (mm): 6
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

93 E8: (0093-5538) Eszopiclone 2 mg Oral Tablet, Film Coated by Avkare, Inc.
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.

NDC Package Codes:

  • 42291-272-90: 90 TABLET, FILM COATED IN 1 BOTTLE (42291‑272‑90)

Active Ingredients:

  • Eszopiclone

Dosage Strength:

  • 2 mg

Inactive Ingredients:

  • Silicon Dioxide
  • Croscarmellose Sodium
  • Calcium Phosphate, Dibasic, Anhydrous
  • Hypromellose 2910 (3 Mpa.s)
  • Hypromellose 2910 (6 Mpa.s)
  • Magnesium Stearate
  • Cellulose, Microcrystalline
  • Polyethylene Glycol 400
  • Titanium Dioxide
  • Polysorbate 80

Related Products:

Based on records with the same trade name.
  • 42291-271 Eszopiclone 1 mg Oral Tablet, Film Coated by Avkare, Inc.
  • 42291-273 Eszopiclone 3 mg Oral Tablet, Film Coated by Avkare, Inc.
  • 0054-0290 Eszopiclone 1 mg Oral Tablet by Roxane Laboratories, Inc.
  • 0054-0291 Eszopiclone 2 mg Oral Tablet by Roxane Laboratories, Inc.
  • 0054-0292 Eszopiclone 3 mg Oral Tablet by Roxane Laboratories, Inc.
  • 0093-5537 Eszopiclone 1 mg Oral Tablet, Film Coated by Teva Pharmaceuticals USA Inc
  • 0093-5538 Eszopiclone 2 mg Oral Tablet, Film Coated by Teva Pharmaceuticals USA Inc
  • 0093-5539 Eszopiclone 3 mg Oral Tablet, Film Coated by Teva Pharmaceuticals USA Inc
  • 0378-5270 Eszopiclone 1 mg Oral Tablet, Film Coated by Mylan Pharmaceuticals Inc.
  • 0378-5271 Eszopiclone 2 mg Oral Tablet, Film Coated by Mylan Pharmaceuticals Inc.
  • 0378-5272 Eszopiclone 3 mg Oral Tablet, Film Coated by Mylan Pharmaceuticals Inc.
  • 33342-299 Eszopiclone 1 mg Oral Tablet, Film Coated by Macleods Pharmaceuticals Limited
  • 33342-300 Eszopiclone 2 mg Oral Tablet, Film Coated by Macleods Pharmaceuticals Limited
  • 33342-301 Eszopiclone 3 mg Oral Tablet, Film Coated by Macleods Pharmaceuticals Limited
  • 42043-320 Eszopiclone 1 mg Oral Tablet, Film Coated by Orchidpharma Inc
  • 42043-321 Eszopiclone 2 mg Oral Tablet, Film Coated by Orchidpharma Inc
  • 42043-322 Eszopiclone 3 mg Oral Tablet, Film Coated by Orchidpharma Inc
  • 43063-795 Eszopiclone 3 mg Oral Tablet, Film Coated by Pd-rx Pharmaceuticals, Inc.
  • 43353-097 Eszopiclone 3 mg Oral Tablet, Film Coated by Aphena Pharma Solutions - Tennessee, LLC
  • 43353-101 Eszopiclone 2 mg Oral Tablet, Film Coated by Aphena Pharma Solutions - Tennessee, LLC
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 42291-272 QR Code

< Prev: 42291-271Next: 42291-273 >

Related Discussions:

Eszopiclone (lunesta) Orange Tablets, no imprints
Small orange/peach round, uncoated pill from INDIA. No markings. They are supposed to be eszopisclone (generic lunesta).... 2 replies
Eszopiclone for old man (87 years old)
My father (87 years old) was consuming clonazepam for long time for sleep, around 1 year, and I think now he is resistan...
Side effects of eszopiclone manufactured by roxane
Are the side effects more common with the manufacturer Roxane versus Teva for the drug eszopiclone? ## No, it is still t... 1 reply




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 24 December 2015.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA